More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.
Tsai
Kuo-Yang
KY
Huang
Chin-Sheng
CS
Huang
Guan-Min
GM
Yu
Chen-Tung
CT
D000368:Aged; D050071:Bone Density Conservation Agents / Q000494:pharmacology / Q000627:therapeutic use; D001861:Bone Regeneration / Q000187:drug effects; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography; D019379:Teriparatide / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019379:Teriparatide